These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 562369)

  • 21. Clinical trials with intranasally administered WRL 105 strain live influenza vaccine in volunteers.
    Freestone DS
    Dev Biol Stand; 1976; 33():207-12. PubMed ID: 782971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children.
    Avila Aguero ML; Soriano-Fallas A; Umaña-Sauma MA; Ulloa-Gutierrez R; Arnoux S
    Medicina (B Aires); 2007; 67(4):351-9. PubMed ID: 17891930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Research on the immunity status of the Turin population with respect to 3 recent variations of influenza A virus].
    Giuliani ; Novara O; Giacobbi D; Paggi GC; Varetti G
    Minerva Med; 1977 Feb; 68(7):443-6. PubMed ID: 840440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Live attenuated influenza virus vaccine trial in children.
    Hall CB; Douglas G; Fralonardo SA
    Pediatrics; 1975 Dec; 56(6):991-8. PubMed ID: 1196767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):393-8. PubMed ID: 18418344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.
    Jadhao SJ; Achenbach J; Swayne DE; Donis R; Cox N; Matsuoka Y
    Vaccine; 2008 Mar; 26(14):1742-50. PubMed ID: 18336962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care.
    Vesikari T; Fleming DM; Aristegui JF; Vertruyen A; Ashkenazi S; Rappaport R; Skinner J; Saville MK; Gruber WC; Forrest BD;
    Pediatrics; 2006 Dec; 118(6):2298-312. PubMed ID: 17142512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza vaccination coverage rates in five European countries-a population-based cross-sectional analysis of two consecutive influenza seasons.
    Szucs TD; Müller D
    Vaccine; 2005 Oct; 23(43):5055-63. PubMed ID: 16046035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM; Li YQ; Zheng TZ; Jia YP; Li F; Han TW; Qiao RX; Zhang BH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):570-3. PubMed ID: 12975010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influenza vaccination with a trivalent whole virus vaccine].
    Schilt U; Burkhardt F; Wegmann A
    Schweiz Med Wochenschr; 1980 Oct; 110(42):1542-5. PubMed ID: 7006073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.
    Rhorer J; Ambrose CS; Dickinson S; Hamilton H; Oleka NA; Malinoski FJ; Wittes J
    Vaccine; 2009 Feb; 27(7):1101-10. PubMed ID: 19095024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
    Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral influenza vaccination with live attenuated viruses. 1. Acceptability, immunogenicity and transmissibility.
    Petrilli FL; Crovari P; Cuneo-Crovari P; Badolati G; Canepa R
    Boll Ist Sieroter Milan; 1975 Oct; 54(4):312-22. PubMed ID: 1203087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
    Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
    Beutner KR; Rizzone C; DeMello S; Ogra PL
    Dev Biol Stand; 1976; 33():162-70. PubMed ID: 782964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of a previous attack of A1 influenza on susceptibility to A2 virus during the 1957 outbreak.
    SLEPUSHKIN AN
    Bull World Health Organ; 1959; 20(2-3):297-301. PubMed ID: 13651915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Seasonal influenza: vaccines available for the winter 2013-2014].
    Leuckx S
    J Pharm Belg; 2013 Sep; (3):25-7. PubMed ID: 24804410
    [No Abstract]   [Full Text] [Related]  

  • 39. [Epidemiological effectiveness of live influenza vaccine during A2 and B influenza outbreaks in 1962].
    Smorodintsev AA; Dokuchaev GI; Minichev PN; Filippov NA; Chalkina OM
    Vopr Virusol; 1965; 10(4):476-82. PubMed ID: 5874477
    [No Abstract]   [Full Text] [Related]  

  • 40. [Inhibitor participation in the regulation of serum RNAse activity in the formation of immunity against influenza].
    Parfenova MS; Maksimovich MB; Bukovetskiĭ SI; Tishechkina VA; Lisovaia SP
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jun; (6):37-41. PubMed ID: 948958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.